0001798749-20-000002.txt : 20200814 0001798749-20-000002.hdr.sgml : 20200814 20200814154029 ACCESSION NUMBER: 0001798749-20-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200814 DATE AS OF CHANGE: 20200814 EFFECTIVENESS DATE: 20200814 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aerovate Therapeutics, Inc. CENTRAL INDEX KEY: 0001798749 IRS NUMBER: 831377888 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-373292 FILM NUMBER: 201104647 BUSINESS ADDRESS: STREET 1: C/O RA CAPITAL MANAGEMENT STREET 2: 200 BERKELEY STREET, 18TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 617-778-2494 MAIL ADDRESS: STREET 1: C/O RA CAPITAL MANAGEMENT STREET 2: 200 BERKELEY STREET, 18TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 D 1 primary_doc.xml X0708 D LIVE 0001798749 Aerovate Therapeutics, Inc. C/O RA CAPITAL MANAGEMENT 200 BERKELEY STREET, 18TH FLOOR BOSTON MA MASSACHUSETTS 02116 617-778-2494 DELAWARE None None Corporation true 2018 Benjamin T. Dake Aerovate Therapeutics Inc. 200 Berkeley Street, 18th Floor Boston MA MASSACHUSETTS 02116 Executive Officer Director David Grayzel Aerovate Therapeutics Inc. 200 Berkeley Street, 18th Floor Boston MA MASSACHUSETTS 02116 Director Maha Katabi Aerovate Therapeutics Inc. 200 Berkeley Street, 18th Floor Boston MA MASSACHUSETTS 02116 Director Jonathan Leff Aerovate Therapeutics Inc. 200 Berkeley Street, 18th Floor Boston MA MASSACHUSETTS 02116 Director Joshua Resnick Aerovate Therapeutics Inc. 200 Berkeley Street, 18th Floor Boston MA MASSACHUSETTS 02116 Director Pharmaceuticals Decline to Disclose 06b false 2020-08-05 false true false 0 75818727 75818727 0 false 9 0 0 0 false Aerovate Therapeutics, Inc. Benjamin T. Dake Benjamin T. Dake President 2020-08-14